company background image
300086 logo

Honz Pharmaceutical SZSE:300086 Stock Report

Last Price

CN¥3.59

Market Cap

CN¥1.6b

7D

-2.7%

1Y

-38.5%

Updated

21 Jun, 2024

Data

Company Financials

Honz Pharmaceutical Co., Ltd.

SZSE:300086 Stock Report

Market Cap: CN¥1.6b

300086 Stock Overview

Engages in the research and development, manufacturing, and sales of pediatric medicines in China.

300086 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Risk Analysis


Honz Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Honz Pharmaceutical
Historical stock prices
Current Share PriceCN¥3.59
52 Week HighCN¥7.20
52 Week LowCN¥3.50
Beta0.70
11 Month Change-17.47%
3 Month Change-30.83%
1 Year Change-38.53%
33 Year Change-37.02%
5 Year Change-40.37%
Change since IPO-71.47%

Recent News & Updates

Recent updates

Shareholder Returns

300086CN PharmaceuticalsCN Market
7D-2.7%-3.7%-1.6%
1Y-38.5%-13.0%-15.7%

Return vs Industry: 300086 underperformed the CN Pharmaceuticals industry which returned -13% over the past year.

Return vs Market: 300086 underperformed the CN Market which returned -15.7% over the past year.

Price Volatility

Is 300086's price volatile compared to industry and market?
300086 volatility
300086 Average Weekly Movement6.4%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 300086's share price has been volatile over the past 3 months.

Volatility Over Time: 300086's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993751Jiangtao Hongwww.honz.com.cn

Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks. It markets its products through a network of agents and sales terminals.

Honz Pharmaceutical Co., Ltd. Fundamentals Summary

How do Honz Pharmaceutical's earnings and revenue compare to its market cap?
300086 fundamental statistics
Market capCN¥1.62b
Earnings (TTM)-CN¥50.39m
Revenue (TTM)CN¥669.71m

2.4x

P/S Ratio

-32.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300086 income statement (TTM)
RevenueCN¥669.71m
Cost of RevenueCN¥262.57m
Gross ProfitCN¥407.14m
Other ExpensesCN¥457.53m
Earnings-CN¥50.39m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin60.79%
Net Profit Margin-7.52%
Debt/Equity Ratio39.6%

How did 300086 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.